Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Acadia Healthcare Company Q3 2026 Results: Net Income $34.5M, Down 4.9% YoY

For the quarter ended September 30, 2026, Acadia Healthcare reported revenue of $895.3 million, a 5.1% increase over the prior year. Net income attributable to the company was $34.5 million, down slightly from $36.2 million in 2025, while the company significantly improved its operating cash flow to $321.5 million for the first nine months of the year.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue895.3851.6
Profit before tax56.540.0
Net income34.536.2
EPS (diluted, $ a share)$0.38$0.40

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-4.9%
Revenue, year on year+5.1%
Source

10-Q filed with the SEC, NASDAQ: ACHC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Acadia Healthcare Company, Inc.: key numbers

Share price
$37.94Close, Nov 17
Market cap
$3.53B
Shares outstanding
92.97MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Specialty Outpatient Facilities, NECSIC 8093

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Acadia Healthcare Company, Inc.

All →
4:11 PM ET 8-K
Financial Results

Acadia Healthcare Company Financial Results

Acadia Healthcare reported Q3 2026 revenue of $895.3 million, a 5.1% increase year-over-year, driven by strong performance in acute inpatient psychiatric facilities. While net income slightly decreased to $34.5 million, the company raised its full-year 2026 financial guidance based on positive operational momentum and facility expansions.

Term
Q3 2026

“Acadia delivered strong results in the third quarter, and our positive momentum is driving our increased full-year guidance. We remain focused on our key priorities, including expanding access to quality patient care and consistent operational execution with financial discipline.”

Debbie Osteen, Chief Executive Officer of Acadia
4:15 PM ET 8-K
Court & Legal Update

Acadia Healthcare Company Court & Legal Update

The U.S. District Court for the Middle District of Tennessee granted preliminary approval for a settlement of several consolidated stockholder derivative actions against Acadia Healthcare and certain individual defendants. The litigation, which includes cases in both Tennessee and Delaware, alleged breaches of fiduciary duty and securities law violations related to matters previously disclosed in 2025. The settlement aims to fully resolve and discharge all released claims nominally asserted on behalf of the company.

Counterparty
Robert Davydov, Margaret Pfenning, and John Solak

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.